Fluorine-19 MRI signal phenotype in solid tumor following in situ perfluorocarbon cell labeling
Eric T Ahrens, Keith Tang, Giuliana P Mognol, Hui Chen, Benjamin I Leach, Andrew Davis, Judith Varner · 2026
Read Fluorine-19 MRI signal phenotype in solid tumor following in situ perfluorocarbon cell labeling by Eric T Ahrens, Keith Tang, Giuliana P Mognol, Hui Chen, Benjamin I Leach, Andrew Davis, Judith Varner (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13470017.txt.
Description
Eric T Ahrens and colleagues validated a fluorine MRI signal in 2026 as a marker of tumour-associated macrophages in breast cancer in mice. Immune cells swallow perfluorocarbon nanoemulsion droplets after injection, giving background-free fluorine images that scale with inflammation. Macrophages can form up to 60% of tumour mass and drive vessel growth, spread, and immune suppression, yet the exact cells behind tumour fluorine signals needed proof.
Flow cytometry, fluorine NMR, and cryo-fluorescence mapping showed selective droplet uptake by myeloid cells in a syngeneic breast tumour model. The work supports fluorine MRI as a noninvasive gauge of macrophage burden, which tracks poor prognosis and weak immunotherapy response. Clinicians could thus image immune context without biopsy, if human translation holds.
Catalog record
| CREATOR | Eric T Ahrens, Keith Tang, Giuliana P Mognol, Hui Chen, Benjamin I Leach, Andrew Davis, Judith Varner |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |